Absolute Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-56
Closed -$2.47K 391
2022
Q3
$2.47K Buy
+56
New +$2.72K ﹤0.01% 287
2022
Q1
Sell
-53
Closed -$3.13K 377
2021
Q4
$3.13K Buy
+53
New +$2.63K ﹤0.01% 286

Other funds holding PFE

Absolute Capital Management's PFE Position: Q4 2022 in Review

Absolute Capital Management sold out of Pfizer (PFE) in Q4 2022, closing a stake of 56 shares — an estimated $2.47K sold.

Absolute Capital Management first reported a position in PFE in Q4 2021 and held it in 2 quarters. The position peaked at $3.13K in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Absolute Capital Management reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Absolute Capital Management sold 56 Pfizer shares in Q4 2022, an estimated $2.47K.
  • Absolute Capital Management first reported a position in Pfizer in Q4 2021 and held it in 2 quarters.
  • Absolute Capital Management's Pfizer position peaked at $3.13K in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Absolute Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.